AaiPharma Fast-Acting Diclofenac NDA Filing Planned For 2002
Executive Summary
AaiPharma plans to submit an NDA by the end of 2002 for its rapidly absorbed diclofenac, claiming a shorter time-to-peak benefit in acute pain.
You may also be interested in...
Patent Reform Bill Drops Changes To Injunctive Relief In Revised Draft
The latest draft of Rep. Lamar Smith's (R-Texas) "Patent Reform Act" drops proposed changes to injunctive relief standards that had been opposed by the pharmaceutical industry
Patent Reform Bill Drops Changes To Injunctive Relief In Revised Draft
The latest draft of Rep. Lamar Smith's (R-Texas) "Patent Reform Act" drops proposed changes to injunctive relief standards that had been opposed by the pharmaceutical industry
Barr Fluoxetine Goal: 80% Generic Penetration In First Six Months
Barr hopes to achieve 80% generic substitution for Lilly's Prozac within the first six months after launch of its generic 20 mg fluoxetine capsules.